Company Data

AlloVir Inc.

Ticker
ALVR
Current Price
$9.63 -2.03%
Market Cap
$48.5M
Price Target
Refer to Report
Volume
5.1K
52wk Range
$7.96 - $24.15
Advanced Market Data

Overview

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm’s pipeline includes ALVR106, ALVR109, ALVR108, and others. The company’s product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy